Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron-regulated surface determinant B protein (IsdB) is a surface-anchored receptor and virulence factor in Staphylococcus aureus, primarily responsible for capturing iron by binding and internalizing heme from host hemoglobin and related proteins; it also interacts with host extracellular matrix proteins such as vitronectin and von Willebrand factor to mediate bacterial adhesion and invasion[1][2][4][7]. IsdB is expressed under iron-starvation conditions and is vital for bacterial growth and virulence in iron-limited host environments. It contains two NEAT (near-iron transporter) domains which separately bind heme and other host proteins, facilitating both iron acquisition and adherence to host cells[2][1]. Consequently, IsdB is a promising therapeutic target for drugs or compounds designed to inhibit bacterial iron uptake and pathogenesis, and is actively being investigated in research for antimicrobial development[7].
Inhibition of IsdB-Hb interaction (blocks iron acquisition, reduces bacterial virulence) Blockade of IsdB-host protein bridging (interferes with adherence/invasion, e.g. via cilengitide interacting with αvβ3 integrins)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-regulated surface determinant B protein (IsdB).